1. Home
  2. CE vs MMSI Comparison

CE vs MMSI Comparison

Compare CE & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celanese Corporation

CE

Celanese Corporation

HOLD

Current Price

$42.49

Market Cap

4.4B

Sector

Industrials

ML Signal

HOLD

MMSI

Merit Medical Systems Inc.

HOLD

Current Price

$86.48

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CE
MMSI
Founded
1918
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.8B
IPO Year
2005
1990

Fundamental Metrics

Financial Performance
Metric
CE
MMSI
Price
$42.49
$86.48
Analyst Decision
Buy
Strong Buy
Analyst Count
18
8
Target Price
$57.33
$105.38
AVG Volume (30 Days)
2.1M
674.7K
Earning Date
11-06-2025
10-30-2025
Dividend Yield
0.28%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.95
Revenue
$9,710,000,000.00
$1,477,128,000.00
Revenue This Year
N/A
$13.53
Revenue Next Year
$0.62
$6.30
P/E Ratio
N/A
$44.42
Revenue Growth
N/A
11.41
52 Week Low
$35.13
$78.12
52 Week High
$75.84
$111.45

Technical Indicators

Market Signals
Indicator
CE
MMSI
Relative Strength Index (RSI) 56.87 55.10
Support Level $39.55 $82.68
Resistance Level $45.02 $88.71
Average True Range (ATR) 1.86 1.67
MACD 0.38 0.09
Stochastic Oscillator 58.31 64.01

Price Performance

Historical Comparison
CE
MMSI

About CE Celanese Corporation

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Share on Social Networks: